- £183.01m
- £194.82m
- £221.25m
- 96
- 75
- 82
- 98
Annual income statement for Supreme, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 92.3 | 122 | 131 | 156 | 221 |
| Cost of Revenue | |||||
| Gross Profit | 26.8 | 33 | 38.5 | 40.9 | 63.5 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 78.3 | 109 | 114 | 140 | 189 |
| Operating Profit | 14 | 13.6 | 17 | 15.4 | 32 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 13.2 | 13 | 16.3 | 14.4 | 30.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 10.9 | 9.84 | 13.7 | 12 | 22.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 10.9 | 9.84 | 13.7 | 12 | 22.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 10.9 | 9.84 | 13.7 | 12 | 22.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.097 | 0.104 | 0.117 | 0.085 | 0.181 |
| Dividends per Share |